Related Experiment Video
Updated: Jun 12, 2026

Isolating and Analyzing Cells of the Pancreas Mesenchyme by Flow Cytometry
Published on: January 28, 2017
MEK1 and MEK2 isoforms regulate distinct functions in pancreatic cancer cells
Lei Zhou1, Xiaodong Tan, Hidenobu Kamohara
1Department of Hepato-pancreato-biliary Tumour Surgery, China Medical University Shengjing Hospital, Shenyang, PR China.
Abstract:
The mitogen-activated protein kinase kinase 1/2 (MEK1/2) signalling pathway plays a central role in tumour progression. Small molecules that inhibit MEK1/2 are therefore considered attractive candidates for anti-cancer drugs. However, the exact contributions of MEK1 and MEK2 to the development of pancreatic cancer remain to be established. To differentiate the functions of MEK1 and MEK2 in a cultured pancreatic cancer cell line, we utilised shRNA-mediated knockdown of their two mRNAs individually. We studied the effects of MEK1 and MEK2 knockdown on cell morphology, proliferation, mitotic arrest, and in vitro invasion capability in PC-1.0 cells. The results showed that inhibition of MEK1 expression was an effective and specific approach to inhibit cell proliferation and induce G0/G1 arrest. On the other hand, MEK2 knockdown specially altered cell morphology and inhibited the invasive ability of pancreatic cancer cells. Therefore, MEK1 and MEK2 mediate different biological responses in cultured pancreatic cancer cells. These proteins could become distinct targets for the inhibition of specific cellular functions in the treatment of pancreatic cancer.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Master Transcription Regulators
PI3K/mTOR/AKT Signaling Pathway
MAPK Signaling Cascades
Abnormal Proliferation
Mitogens and the Cell Cycle
